Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT00989690 · UNKNOWN
Trial details
- NCT number
- NCT00989690
- Sponsor
- Istituto Scientifico H. San Raffaele
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.